CD19- BCMA CAR-T cells: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Condition	Trials
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	1
Autoimmune Diseases	1
Granulomatous Polyangiitis	1
Idiopathic Inflammatory Myopathies	1
Lupus	1
Lupus Nephritis	1
Microscopic Polyangiitis	1
Rheumatoid arthritis	1
Sjogren's Syndrome	1
Systemic Lupus Erythematosus	1
Systemic Sclerosis	1

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
NCT06350110 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location

1 recruiting trial across 11 conditions.

No. For the full record, search ClinicalTrials.gov.